Biochem/physiol Actions
E7820 (NSC 719239) is an orally available anticancer and antiangiogenic agent that inhibits VEGF-2 or FGF-2-induced tube formation of HUVEC cells through the suppression of integrin α2. E7820 promotes selective proteasomal degradation of the U2AF-related splicing factor CAPERα (coactivator of activating protein-1 and estrogen receptors) by ubiquitination and degradation via CRL4DCAF15.
- UPC:
- 41113714
- Condition:
- New
- HazmatClass:
- No
- MPN:
- SML2950-25MG
- CAS:
- 289483-69-8
akash.verma@cenmed.com
(732) 447-1115





